QNS7h
Council Member Sandra Ung to host free hepatitis B screening in Flushing next month
Council Member Sandra Ung and leaders from the Charles B. Wang Community Health Center will host a free hepatitis B screening ...
GEN20h
HBV’s Ability to Infect Human Liver Cells Thwarted by Potential Anticancer Drug
Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.
Dynavax projects HEPLISAV-B revenue of $305M-$325M for 2025 amid expanding hepatitis B market
Dynavax reports record HEPLISAV-B revenue, 26% growth in 2024, and strong 2025 guidance. Insights on shingles vaccine progress & market expansion.
Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV
The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.
Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate
Precision BioSciences, Inc. (NASDAQ:DTIL) revealed initial results from the first administration of PBGENE-HBV in cohort 1, ...
Precision BioSciences announces initial results from ELIMINATE-B trial
Precision BioSciences (DTIL) announced initial results from the first administration of PBGENE-HBV in cohort 1, the lowest dose level of the ...
The Lancet2d
Non-invasive tests for assessing liver fibrosis and cirrhosis in chronic hepatitis B
Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...